Interferon-γ 1b: impact of new indications (idiopathic pulmonary fibrosis)
AN Aggarwal, D Behera - Expert Opinion on Pharmacotherapy, 2000 - Taylor & Francis
Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease with inadequate
response to conventional treatment with corticosteroids and/or immunosuppressive agents …
response to conventional treatment with corticosteroids and/or immunosuppressive agents …
Interferon-gamma 1b: impact of new indications (idiopathic pulmonary fibrosis).
AN Aggarwal, D Behera - Expert Opinion on Pharmacotherapy, 2000 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease with inadequate
response to conventional treatment with corticosteroids and/or immunosuppressive agents …
response to conventional treatment with corticosteroids and/or immunosuppressive agents …
Interferon-gamma 1b: impact of new indications (idiopathic pulmonary fibrosis)
AN Aggarwal, D Behera - Expert opinion on …, 2000 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease with inadequate
response to conventional treatment with corticosteroids and/or immunosuppressive agents …
response to conventional treatment with corticosteroids and/or immunosuppressive agents …